"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss drugs. Set ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Dan Bessesen, MD, a health and wellness leader at CU Anschutz, offers key insights on weight loss drugs, particularly compounded GLP-1s that are banned by the FDA but continue to be available.

Compounded drugs are custom-made medications by a licensed pharmacist or pharmacy technician. They alter ingredients, drug form, or dosage amounts to create a medication tailored to an individual’s ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...

SILVER SPRING, Md. - Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as GLP-1s. The FDA says compounding pharmacies, ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded drugs ...

(Reuters) -A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s blockbuster weight loss and diabetes drugs off its list of ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

CDSCO introduces guidelines for compounding offences, streamlining compliance for pharma firms and minimizing court appearances for minor contraventions.